Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.

Bansal S, Berk M, Alkhouri N, Partrick DA, Fung JJ, Feldstein A.

J Surg Res. 2014 Jan;186(1):29-38. doi: 10.1016/j.jss.2013.07.001. Epub 2013 Jul 27.

2.

Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.

Lai KKY, Kweon SM, Chi F, Hwang E, Kabe Y, Higashiyama R, Qin L, Yan R, Wu RP, Lai K, Fujii N, French S, Xu J, Wang JY, Murali R, Mishra L, Lee JS, Ntambi JM, Tsukamoto H.

Gastroenterology. 2017 May;152(6):1477-1491. doi: 10.1053/j.gastro.2017.01.021. Epub 2017 Jan 29.

PMID:
28143772
3.

Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.

Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M.

Gastroenterology. 2011 Mar;140(3):1071-83. doi: 10.1053/j.gastro.2010.12.006. Epub 2010 Dec 11.

4.

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H.

World J Gastroenterol. 2009 Dec 21;15(47):5924-35.

5.

FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.

Du X, Wang QR, Chan E, Merchant M, Liu J, French D, Ashkenazi A, Qing J.

Cancer Res. 2012 Nov 15;72(22):5843-55. doi: 10.1158/0008-5472.CAN-12-1329. Epub 2012 Sep 26.

6.
7.

SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway.

Huang GM, Jiang QH, Cai C, Qu M, Shen W.

Cancer Lett. 2015 Mar 28;358(2):180-90. doi: 10.1016/j.canlet.2014.12.036. Epub 2014 Dec 17.

PMID:
25528629
8.

Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.

Yang WL, Wei L, Huang WQ, Li R, Shen WY, Liu JY, Xu JM, Li B, Qin Y.

Oncol Rep. 2014 May;31(5):2328-34. doi: 10.3892/or.2014.3111. Epub 2014 Mar 24.

PMID:
24676454
9.
10.

MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.

Zhao LY, Zhang J, Guo B, Yang J, Han J, Zhao XG, Wang XF, Liu LY, Li ZF, Song TS, Huang C.

Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;Suppl 59:OL1876-81.

PMID:
24199952
11.

HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.

Xiao Q, Qu K, Wang C, Kong Y, Liu C, Jiang D, Saiyin H, Jia F, Ni C, Chen T, Zhang Y, Zhang P, Qin W, Sun Q, Wang H, Yi Q, Liu J, Huang H, Yu L.

Gut. 2013 Mar;62(3):440-51. doi: 10.1136/gutjnl-2011-300781. Epub 2012 Apr 5.

PMID:
22490522
12.

8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK.

Yang XH, Zheng X, Cao JG, Xiang HL, Liu F, Lv Y.

World J Gastroenterol. 2010 Jul 21;16(27):3385-93.

13.

P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.

Fang ZP, Jiang BG, Gu XF, Zhao B, Ge RL, Zhang FB.

Acta Pharmacol Sin. 2014 Jan;35(1):82-8. doi: 10.1038/aps.2013.31. Epub 2013 May 20.

14.

Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.

Ninomiya S, Shimizu M, Imai K, Takai K, Shiraki M, Hara T, Tsurumi H, Ishizaki S, Moriwaki H.

Cancer Prev Res (Phila). 2011 Dec;4(12):2092-100. doi: 10.1158/1940-6207.CAPR-11-0340. Epub 2011 Sep 27.

15.

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.

Cancer Res. 2009 Feb 15;69(4):1358-67. doi: 10.1158/0008-5472.CAN-08-2545. Epub 2009 Feb 3.

16.
17.

Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.

Cuconati A, Mills C, Goddard C, Zhang X, Yu W, Guo H, Xu X, Block TM.

PLoS One. 2013;8(1):e54595. doi: 10.1371/journal.pone.0054595. Epub 2013 Jan 23.

18.

Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.

Miao J, Chen GG, Chun SY, Chak EC, Lai PB.

Int J Oncol. 2004 Sep;25(3):651-9.

PMID:
15289866
19.

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.

Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM.

J Am Coll Surg. 2004 Mar;198(3):410-21.

PMID:
14992744
20.

Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.

Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, Feng G, Zou D, Wang H.

Clin Cancer Res. 2013 Oct 1;19(19):5372-80. doi: 10.1158/1078-0432.CCR-13-0203. Epub 2013 Aug 13.

Supplemental Content

Support Center